Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Learn what questions to ask a financial advisor as a new investor. Empower yourself with the right information for success.
27,223 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Investors flooded crypto funds with $858M in inflows as lawmakers push a clarity-focused framework for stablecoins. T...
Fermi’s stock jump today highlights how earnings, project milestones, and strategic pivots shape appetite for AI infr...
On a day when market indexes drift lower, a single retailer can move the needle while tech breakthroughs push a diffe...
From top holdings to regulatory risks, this guide breaks down ZKH's Q1 2026 earnings call and translates the numbers ...
As bond markets evolve, a widely used bond ETF faces renewed scrutiny over cost and hedging power. Investors are aske...
The quantum computing sector has faced a pullback, but not every hire is a misfire. This article breaks down the rece...
Investors are watching Micron ahead of earnings day. This guide breaks down three essential signals that could push M...
Progressive Insurance fell today as markets weighed mixed quarterly results. This article breaks down the numbers, ex...
When a Federal Reserve chair signals a preference for policy stability over boom-and-bust cycles, it can upend how in...
Discover how Claros Mortgage Trust CMTG generates income, navigates rate risk, and positions its portfolio for the ne...
Moneco Advisors recently boosted its stake in a bulletShares 2032 ETF, signaling a strategic tilt toward long-dated i...